Organon shares trade at a discount, but there are no strong drivers for business growth. Click here to find out why I am neutral on OGN stock.
Organon Sub-Saharan Africa deepened its leadership on women’s health and family planning at the WHX Leaders’ Summit in Accra, ...
Women’s health company Organon is selling off its postpartum uterine bleeding or hemorrhage system to Laborie Medical Technologies in a deal worth up to $465 million. Organon first gained access to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback